Detalhe da pesquisa
1.
Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital.
Breast Cancer Res Treat
; 195(3): 333-340, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35976513
2.
A review on the added value of whole-body MRI in metastatic lobular breast cancer.
Eur Radiol
; 32(9): 6514-6525, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384456
3.
Impact of timing of adjuvant chemothapy for early breast cancer: the Royal Marsden Hospital experience.
Br J Cancer
; 125(2): 299-304, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34017085
4.
Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial.
Lancet Oncol
; 18(3): 357-370, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28163000
5.
Systemic Therapies for HER2-Positive Advanced Breast Cancer.
Cancers (Basel)
; 16(1)2023 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38201451
6.
Vinorelbine After Prior Treatment With Eribulin for Advanced Breast Cancer: A Single-Centre Experience Suggesting Cross-Resistance.
Clin Breast Cancer
; 22(7): e825-e831, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35840514
7.
Does the addition of whole-body MRI to routine imaging influence real-world treatment decisions in metastatic breast cancer?
Cancer Imaging
; 22(1): 26, 2022 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35672838
8.
Targeting angiogenesis in esophagogastric adenocarcinoma.
Oncologist
; 16(6): 844-58, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21632459
9.
Treating Advanced Unresectable or Metastatic HER2-Positive Breast Cancer: A Spotlight on Tucatinib.
Breast Cancer (Dove Med Press)
; 13: 361-381, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34079368
10.
Heterogeneous HER2 Amplification-a New Clinical Category of HER2-Positive Breast Cancer?
Cancer Discov
; 11(10): 2369-2371, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34598949
11.
Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in PIK3CA-Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid Cancers.
Cancer Discov
; 11(1): 92-107, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32958578
12.
Inactivating NF1 Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance.
Clin Cancer Res
; 26(3): 608-622, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31591187
13.
To Cycle or Fight-CDK4/6 Inhibitors at the Crossroads of Anticancer Immunity.
Clin Cancer Res
; 25(1): 21-28, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30224338
14.
Capecitabine and oxaliplatin for advanced esophagogastric cancer.
N Engl J Med
; 362(9): 858-9, 2010 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20200397
15.
An evaluation of FIGO 2000: the first 5 years.
J Reprod Med
; 53(8): 615-22, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18773627
16.
Genomic loss of heterozygosity and survival in the REAL3 trial.
Oncotarget
; 9(94): 36654-36665, 2018 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30613349
17.
Investigational antibody-drug conjugates in clinical trials for the treatment of breast cancer.
Expert Opin Investig Drugs
; 30(8): 789-795, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34114911
18.
Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial.
J Clin Oncol
; 34(23): 2721-7, 2016 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27298411
19.
Current and Future Therapies for Advanced Gastric Cancer.
Clin Colorectal Cancer
; 14(4): 239-50, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26524924
20.
Trastuzumab: a novel standard option for patients with HER-2-positive advanced gastric or gastro-oesophageal junction cancer.
Therap Adv Gastroenterol
; 5(5): 301-18, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22973416